Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study

BMC Cardiovascular Disorders
Mequanent Kassa Birarra, Dessalegn Asmelashe Gelayee

Abstract

Metabolic syndrome (MetS) increases risk of cardiovascular diseases (CVD), premature death as well as cost related to health care.This study was aimed at investigating the prevalence of MetS and its determinant factors among type2 diabetes mellitus (T2DM) patients attending a specialized hospital. A cross-sectional study was conducted on a total of 256 T2DM patients from the first march to 30th May 2017 at university of gondar comprehensive specialized hospital (UGCSH). Data was collected based on STROBE (strengthening the reporting of observational studies in epidemiology) statement. Bivariable and multivariable logistic regression analysis were run to identify predictors of MetS from the independent variables and significance test was set at P <  0.05. The prevalence of MetS in this study was 70.3, 57 & 45.3% and it is more common in females (66.1, 83.3 & 70.7%) by using national cholesterol education program adult treatment panel III (NCEP-ATP III), International diabetic federation (IDF) and world health organization (WHO) criteria respectively. The most prevalent components of MetS were low level of high density lipoprotein (HDL) and triglyceride(TG). By usingIDF criteria, female gender was significantly associated with Me...Continue Reading

References

Jul 1, 1989·Disease-a-month : DM·G A Bray
May 11, 2000·The New England Journal of Medicine·M ChandaliaL J Brinkley
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Nov 5, 2003·Journal of Hypertension·Daniel LemogoumUNKNOWN International Forum for Hypertension control and prevention in Africa
Feb 16, 2005·Annual Review of Physiology·Evangelia CharmandariGeorge Chrousos
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
Sep 27, 2006·The American Journal of Medicine·Andrea GalassiJiang He
May 10, 2007·The Review of Diabetic Studies : RDS·Christos PitsavosChristodoulos Stefanadis
Sep 26, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Rhonda Bentley-LewisEllen W Seely
Aug 23, 2008·The Tohoku Journal of Experimental Medicine·Aya MorimotoNaoko Tajima
Jun 30, 2009·Metabolic Syndrome and Related Disorders·D M BoudreauL J Okamoto
Jul 14, 2010·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A A RivelleseO Vaccaro
Aug 20, 2011·Clinical Journal of the American Society of Nephrology : CJASN·George ThomasSankar D Navaneethan
Mar 28, 2013·International Journal of Hypertension·Alessandra Saldanha de Mattos MatheusMarilia de Brito Gomes
Dec 4, 2014·Journal of Diabetes and Metabolic Disorders·Daya Ram PokharelPramod Shankar Shukla
Dec 17, 2014·Globalization and Health·Sheikh Mohammed Shariful IslamGünter Fröschl
Jun 23, 2015·International Journal of Applied & Basic Medical Research·Kwabena NsiahF O Mensah
Mar 18, 2016·Journal of Family Medicine and Primary Care·Sasthi Narayan ChakrabortyMd Abdur Rahaman
Mar 22, 2016·JRSM Cardiovascular Disease·Thang S Han, Mike Ej Lean
Mar 4, 2018·BMC Public Health·Mohammad Ziaul Islam ChowdhuryTanvir C Turin

❮ Previous
Next ❯

Citations

Oct 28, 2019·Journal of Physiological Anthropology·Makeda SinagaTefera Belachew
Jul 2, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Melkamu Merid MengeshaHirbo Shore Roba
Jan 24, 2021·Diabetes & Metabolic Syndrome·Bayu Begashaw BekeleSeithikurippu R Pandi-Perumal
Feb 20, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Gebremedhin GebreegziabiherDessalegn Tamiru
Mar 6, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Bizuayehu WalleHordofa Gutema
Aug 7, 2020·Diabetes & Metabolic Syndrome·Wondimeneh Shibabaw ShiferawYared Asmare Aynalem
Apr 2, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Xi YangLi Li
Jul 6, 2021·Journal of Diabetes and Metabolic Disorders·Tadeg Jemere, Belayneh Kefale

❮ Previous
Next ❯

Methods Mentioned

BETA
hormonal replacement therapy
amputation

Software Mentioned

statistical package for the social sciences ( SPSS )
Epi Info

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

Diabetes Research and Clinical Practice
Wan Nazaimoon Wan MohamudWan Mohamad Wan Bebakar
Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
Angel Rodríguez BernardinoManuel Serrano Ríos
Romanian Journal of Internal Medicine = Revue Roumaine De Médecine Interne
Lucica Agoşton-ColdeaS Perna
© 2022 Meta ULC. All rights reserved